Axis Advocacy Attending The 10th Annual Sickle Cell in Focus

day1

Sickle Cell in Focus (SCiF) is an annual two-day intensive and educational conference co-hosted by the National Heart, Lung and Blood Institutes (NHLBI) in Washington, DC and the South Thames Sickle Cell & Thalassaemia Network (STSTN) in London, UK. It highlights and discusses the emerging clinical complications and clinical management of sickle cell disease. The clinical and scientific research lectures are aimed at an audience of consultants, academics, trainee doctors and health professionals involved in the care of patients with the disease. It attracts local, national and international guest speakers and delegates.

hd_video_icon WATCH: Sickle Cell in Focus Conference 2016 – Day 1

Axis Advocacy covered the events.

 Day 1: June 2nd, DAY ONE: THURSDAY 2nd JUNE 2016

Adrienne and Nancy at the 10th Annual NIH Focus on Sickle Cell Meeting

Dr. Gary Gibbons Director NIH – Keynote speaker

dr Gary Gibbons Director NIH - Keynote speaker

Nancy speaking with meeting chair Kwaku Ohene-Frempong

Nancy speaking with meeting chair Kwaku Ohene-Frempong

Dr. Aly Diallo, MD

Dr. Aly Diallo, MD

Audience of scientists, researchers and advocates.

Dr Elliot Vichinsky MD – UCSF Benioff Children’s Hospital Oakland; Director, Northern California Sickle Cell and Thalassemia Center “Axis Advocacy Buddy”

Dr Elliot Vichinsky MD - UCSF Benioff Children's Hospital Oakland; Director, Northern California Sickle Cell and Thalassemia Center "Axis Advocacy Buddy"

Dr Tom White “Sickle Cell Trait protects you from affects of Malaria.”

Dr Tom White "Sickle Cell Trait protects you from affects of malaria"

Dr. Hans Ackerman, The impact of iron availability on malaria and sickle cell disease severity.

Hans Ackerman

Co-Founder, Nancy Rene

Dr. Ming Dao speaks on a microfluidic platform to assess biorheology in malaria and sickle cell disease

Ming Dao

Dr. Fayyaz Sutterwala speaks on Inflammasomes in health and disease

Dr. Fayyaz Sutterwala

Dr. John Belcher discusses TLRs, inflammation and sickle cell disease – the innate connection.

Dr. John Belcher

Dr. Deepa Manwani speaks about clinical trials.

Dr. John Horan discusses bone marrow transplants.

The Great Debate : HSCT is recommended for Secondary Prevention of Cerebrovascular Infarcts in SCD. Pro – Dr. Michael DeBaun Con – Dr. Elliot Vinchinsky.

The Great Debate, Pro: Dr. Michael DeBaun

The Great Debate, Con: Dr. Elliott Vichinsky

This concludes day 1 of Sickle Cell in Focus (SCiF) conference, Washington D.C.